Scarica l'app Stockscreener
0.3601
12.17%
-0.0499
Pre-mercato:
.39
0.0299
+8.30%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché TTOO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.41
Aprire:
$0.41
Volume 24 ore:
1.01M
Relative Volume:
1.16
Capitalizzazione di mercato:
$7.58M
Reddito:
$7.19M
Utile/perdita netta:
$-50.08M
Rapporto P/E:
-0.00247
EPS:
-145.9978
Flusso di cassa netto:
$-48.33M
1 W Prestazione:
-9.98%
1M Prestazione:
-30.75%
6M Prestazione:
-92.56%
1 anno Prestazione:
-93.09%
Intervallo 1D:
$0.3489
$0.42
Intervallo di 1 settimana:
$0.3489
$0.43
Portata 52W:
$0.31
$6.95
T 2 Biosystems Inc Stock (TTOO) Company Profile
Nome
T 2 Biosystems Inc
Settore
Industria
Telefono
781-457-1200
Indirizzo
101 HARTWELL AVENUE, LEXINGTON
Confronta TTOO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TTOO
T 2 Biosystems Inc
|
0.3601 | 7.58M | 7.19M | -50.08M | -48.33M | -146.00 |
|
TMO
Thermo Fisher Scientific Inc
|
544.93 | 208.44B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
238.09 | 171.97B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
137.00 | 39.13B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
204.32 | 37.08B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
432.36 | 35.40B | 3.84B | 866.24M | 792.60M | 10.37 |
T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-01-27 | Downgrade | Alliance Global Partners | Buy → Neutral |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2019-11-26 | Downgrade | Janney | Buy → Neutral |
| 2019-08-01 | Downgrade | Alliance Global Partners | Buy → Neutral |
| 2019-07-31 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2019-07-31 | Downgrade | Janney | Buy → Neutral |
| 2019-05-16 | Iniziato | Alliance Global Partners | Buy |
| 2019-03-08 | Reiterato | H.C. Wainwright | Buy |
| 2018-06-01 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-05-30 | Reiterato | H.C. Wainwright | Buy |
| 2018-05-29 | Reiterato | WBB Securities | Strong Buy |
| 2018-03-29 | Reiterato | H.C. Wainwright | Buy |
| 2018-01-29 | Iniziato | Goldman | Neutral |
| 2017-10-18 | Iniziato | H.C. Wainwright | Buy |
| 2017-03-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2016-11-10 | Ripresa | Leerink Partners | Mkt Perform |
| 2016-11-02 | Reiterato | Cantor Fitzgerald | Buy |
| 2016-07-20 | Aggiornamento | WBB Securities | Buy → Strong Buy |
| 2016-06-22 | Aggiornamento | WBB Securities | Speculative Buy → Buy |
| 2016-04-12 | Reiterato | Canaccord Genuity | Buy |
| 2016-02-17 | Iniziato | WBB Securities | Speculative Buy |
Mostra tutto
T 2 Biosystems Inc Borsa (TTOO) Ultime notizie
T2 Biosystems Reports Strong Financial Performance and Strategic Developments - Defense World
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
T2 Biosystems Achieves Record Revenue Growth, Expands Global Reach with 27 New Instrument Contracts - StockTitan
T2 Biosystems announces board changes and incentive plan approval - Investing.com India
T2 Biosystems announces board changes and incentive plan approval By Investing.com - Investing.com South Africa
T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com - Defense World
T2 Biosystems Announces Amendments and Voting Results from Annual Meeting**Lexington, Massachusetts – T2 Biosystems, Inc. (NASDAQ: TTOO) recently disclosed significant updates from its recent Annual Meeting with stockholders held on December 3 - Defense World
T2 Biosystems Enhances Governance and Leadership Stability - MSN
T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com - Defense World
T2 Biosystems (NASDAQ:TTOO) Coverage Initiated at StockNews.com - Defense World
T2 Biosystems sells four T2Dx Instruments to European distributor - MSN
T2 Biosystems expands EU presence with instrument sales By Investing.com - Investing.com Australia
Before You Invest, Make Sure You Check This T2 Biosystems Inc (NASDAQ: TTOO) Analysis - Stocks Register
T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor - citybiz
T2 Biosystems Expands International Market Presence with Sale of Four T2Dx® Instruments to European Distributor - Nasdaq
T2 Biosystems expands EU presence with instrument sales - Investing.com
T2 Biosystems Expands European Footprint with Strategic T2Dx Instrument Sales, Breakthrough Clinical Data - StockTitan
T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally - The Manila Times
T2 Biosystems' Revolutionary Sepsis Tests Hit 250K Milestone, Slash Detection Time by 77 Hours - StockTitan
T2 Biosystems extends Vizient supplier agreement By Investing.com - Investing.com Canada
T2 Biosystems extends Vizient supplier agreement - Investing.com India
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc - Marketscreener.com
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. - The Manila Times
T2 Biosystems (NASDAQ:TTOO) Receives Delisting Notice from Nasdaq**Lexington, Massachusetts-based T2 Biosystems, Inc. (NASDAQ:TTOO) recently disclosed in an 8-K filing with the Securities and Exchange Commission (SEC) that it has received a notif - Defense World
T2 Biosystems stock plunges to 52-week low of $0.41 By Investing.com - Investing.com South Africa
T2 Biosystems faces Nasdaq delisting over share price - Investing.com
T2 Biosystems stock plunges to 52-week low of $0.41 - Investing.com
T2 Biosystems expands its leadership in direct-from-whole-blood detection of sepsis-causing pathogens - SelectScience
T2 Biosystems to license sepsis detection tech By Investing.com - Investing.com Canada
T2 Biosystems to license sepsis detection tech - Investing.com India
T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens - The Manila Times
T2 Biosystems Announces Plans to License its Proprietary - GlobeNewswire
T2 Biosystems Inc (NASDAQ: TTOO) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems stock plunges to 52-week low of $0.44 By Investing.com - Investing.com Canada
T2 Biosystems stock plunges to 52-week low of $0.44 - Investing.com
T2 Biosystems Reports Strong Q3 Financial Results and Operational Updates - Defense World
T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2024 Earnings Call Transcript - Insider Monkey
T2 Biosystems: Q3 Earnings Snapshot - mySA
Earnings call: T2 Biosystems reports growth and strategic partnerships - Investing.com
Earnings call: T2 Biosystems reports growth and strategic partnerships By Investing.com - Investing.com UK
Analysis of ARMISTICE CAPITAL, LLC's Recent Trade in T2 Biosyste - GuruFocus.com
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
T 2 Biosystems Inc Azioni (TTOO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.34%
0.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):